H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
RWJF presents 2009 Community Health Leaders Award to New York City ER doctor

RWJF presents 2009 Community Health Leaders Award to New York City ER doctor

HHS unveils several new resources on federal government’s website for flu information

HHS unveils several new resources on federal government’s website for flu information

CEL-SCI Corporation reports on its dendritic H1N1 treatment

CEL-SCI Corporation reports on its dendritic H1N1 treatment

Health experts recommend schools to use new web-based tools in view of upcoming flu season

Health experts recommend schools to use new web-based tools in view of upcoming flu season

Rite Aid pharmacists provide regular seasonal flu shots to help prevent flu

Rite Aid pharmacists provide regular seasonal flu shots to help prevent flu

Experts to develop effective surveillance system to monitor emerging infections at global level

Experts to develop effective surveillance system to monitor emerging infections at global level

Swine flu may levy higher toll on minorities

Swine flu may levy higher toll on minorities

HTDS' Hepatitis A vaccine receives GMP Certificate from the Russian FDA

HTDS' Hepatitis A vaccine receives GMP Certificate from the Russian FDA

Global pharmaceutical market to grow by 4 - 6 percent: IMS Health

Global pharmaceutical market to grow by 4 - 6 percent: IMS Health

The Prescription Center Pharmacy launches 'Be Prepared, Not Scared' campaign

The Prescription Center Pharmacy launches 'Be Prepared, Not Scared' campaign

WHO emphasizes H1N1 vaccine safety

WHO emphasizes H1N1 vaccine safety

Swine Flu prevention tips from California dentists

Swine Flu prevention tips from California dentists

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Microsoft launches a new online H1N1 Flu Response Center

Microsoft launches a new online H1N1 Flu Response Center

Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccine

Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccine

HTDS receives follow up report and files with Pink Sheets

HTDS receives follow up report and files with Pink Sheets

Autism rates among U.S. children is one in 91, says new report

Autism rates among U.S. children is one in 91, says new report

Swine Flu vaccine arrives as flu moves quickly through population

Swine Flu vaccine arrives as flu moves quickly through population

Today's editorials and opinions

Today's editorials and opinions

Mexican Health Minister to discuss preparations and responses to H1N1 influenza

Mexican Health Minister to discuss preparations and responses to H1N1 influenza

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.